Trump says trade war with China will be fairly short

MORRISTOWN, N.J. (Reuters) - U.S. President Donald Trump said on Thursday he believes China wants to make a trade deal and the trade war with Beijing will be fairly short

Reuters August 16, 2019 04:05:18 IST
Trump says trade war with China will be fairly short

Trump says trade war with China will be fairly short

MORRISTOWN, N.J. (Reuters) - U.S. President Donald Trump said on Thursday he believes China wants to make a trade deal and the trade war with Beijing will be fairly short.

"I think we're having very good discussions with China. They very much want to make a deal," Trump told reporters. He said he had a call scheduled soon with Chinese President Xi Jinping, but he did not say when.

"I think the longer it goes the stronger we get," Trump said of the trade war. "I have a feeling it's going to go fairly short," he said.

China on Thursday vowed to counter the latest U.S. tariffs on $300 billion of Chinese goods but called on the United States to meet it halfway on a potential trade deal.

Trump said he did not think Beijing would retaliate for the U.S. tariffs.

U.S. and Chinese trade negotiators are set to meet next month in Washington, though a specific date has not been announced.

"September, the meeting is still on as I understand it, but I think more importantly than September, we're talking by phone, and we're having very productive talks," Trump said.

He said U.S. and Chinese officials had "a very good conversation" a few days ago.

(Reporting by Steve Holland; Writing by Eric Beech; Editing by Chris Reese and Sandra Maler)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Gilead nears deal to buy Immunomedics for more than $20 billion, WSJ reports
Business

Gilead nears deal to buy Immunomedics for more than $20 billion, WSJ reports

(Reuters) - Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than $20 billion, the Wall Street Journal reported on Saturday, citing people familiar with the matter. A deal for Immunomedics, which last month reported positive data from a late-stage study for its breast-cancer drug, could be announced Monday if not sooner, the Journal said https://www.wsj.com/articles/gilead-nears-deal-to-buy-immunomedics-for-more-than-20-billion-11599936777?mod=hp_lead_pos2. Gilead and Immunomedics did not respond immediately to emailed requests from Reuters for comment

China bans German pork imports after African swine fever case
Business

China bans German pork imports after African swine fever case

SHANGHAI (Reuters) - China banned pork imports from Germany on Saturday after it confirmed its first case of African swine fever last week, in a move set to hit German producers and push up global prices as China's meat supplies tighten. China's ban on imports from its third largest supplier comes as the world's top meat buyer deals with an unprecedented pork shortage after its own epidemic of the deadly hog disease. The ban on Germany, which has supplied about 14% of China's pork imports so far this year, will push up demand for meat from other major suppliers like the United States and Spain, boosting global prices.

Libya's Haftar committed to ending oil blockade, U.S. says
Business

Libya's Haftar committed to ending oil blockade, U.S. says

CAIRO (Reuters) - Libyan commander Khalifa Haftar has committed to ending a months-long blockade of oil facilities, the U.S.